Revenue | ₹204.30Cr |
Net Profits | ₹-5.72Cr |
Net Profit Margins | -2.80% |
Orchid Pharma Ltd’s revenue fell -11.26% since last year same period to ₹204.30Cr in the Q2 2025-2026. On a quarterly growth basis, Orchid Pharma Ltd has generated 10.8% jump in its revenue since last 3-months.
Orchid Pharma Ltd’s net profit fell -121% since last year same period to ₹-5.72Cr in the Q2 2025-2026. On a quarterly growth basis, Orchid Pharma Ltd has generated -138.36% fall in its net profits since last 3-months.
Orchid Pharma Ltd’s net profit margin fell -123.66% since last year same period to -2.80% in the Q2 2025-2026. On a quarterly growth basis, Orchid Pharma Ltd has generated -134.62% fall in its net profit margins since last 3-months.
The revenue for Orchid Pharma Ltd in the Q2 results 2025 was ₹204.30Cr.
The net profit for Orchid Pharma Ltd in the Q2 results 2025 was ₹-5.72Cr.
The net profit margin for Orchid Pharma Ltd in the Q2 results 2025 was -2.80%.
The revenue for Orchid Pharma Ltd in the Q2 results 2024 was ₹230.22Cr.
The net profit for Orchid Pharma Ltd in the Q2 results 2024 was ₹27.24Cr.
The net profit margin for Orchid Pharma Ltd in the Q2 results 2024 was 11.83%.